Marketing In Brief
This article was originally published in The Rose Sheet
Executive Summary
Coty: Firm introduces limited editions of Marc Jacobs scents Daisy andLola. Daisy Marc Jacobs Pop Art Edition captures "the polish of uptown luxury and a relaxed downtown vibe" with a shiny red lacquered bottle featuring a white logo and black and gold daisies radiating from the cap. The 3.4-oz. fragrance will be available in August at department stores for $88. To celebrate Lola's first anniversary, a velvet edition featuring the original fragrance in a collectible bottle will launch in July at Bloomingdales and in August at specialty retailers at $68 for 1.7 oz. Designed by Jacobs, the violet-colored frosted glass bottle with soft colorful velvet flower petals "blooming" from the cap reflects his "sophistication mixed with a touch of mischief." Additionally, firm launches Vera Wang Anniversary, playing homage to the "classic Vera Wang bottle, redefining it with a touch of color and texture." The bottle is decorated with lavender petals - "revealing the lavender juice within" - and topped with a clear glass cap and platinum collar. Eau de parfum - 1.7 oz. for $72 or 3.4 oz. for $92 - and $25 shimmer rollerball will be available in department stores in September
You may also be interested in...
AmStem optimistic about study results
San Francisco-based firm - whose Korean facility houses one of the largest banks in the world for umbilical-cord-derived stem cells - announces positive early results from a preliminary consumer study of its SteMixx face cream. More than 64% of responding participants from 21-woman study have made positive comments about the product, says AmStem, which will release full results at the end of the month. Based on initial feedback, "AmStem has engaged a labeling consultant ... to make [SteMixx] available for retail consumer use as soon as possible in the U.S." Firm also says it has finalized its submission to an institutional review board to begin first clinical trial of SteMixx in the U.S. (1"The Rose Sheet" June 21, 2010, Marketing In Brief). SteMixx employs Human Stem Cell Conditioned Media, created during culture of umbilical cord stem cells, to stimulate user's own inherent skin cells and promote skin rejuvenation
AmStem optimistic about study results
San Francisco-based firm - whose Korean facility houses one of the largest banks in the world for umbilical-cord-derived stem cells - announces positive early results from a preliminary consumer study of its SteMixx face cream. More than 64% of responding participants from 21-woman study have made positive comments about the product, says AmStem, which will release full results at the end of the month. Based on initial feedback, "AmStem has engaged a labeling consultant ... to make [SteMixx] available for retail consumer use as soon as possible in the U.S." Firm also says it has finalized its submission to an institutional review board to begin first clinical trial of SteMixx in the U.S. (1"The Rose Sheet" June 21, 2010, Marketing In Brief). SteMixx employs Human Stem Cell Conditioned Media, created during culture of umbilical cord stem cells, to stimulate user's own inherent skin cells and promote skin rejuvenation
Face Cream Derived From Human Umbilical Stem Cells Aimed At U.S. Market
An agreement between soon-to-merge South Korean firm Histostem and Tampa, Fla.-based Stem Cell Therapy International is expected to deliver a skin-care product derived from human umbilical cord stem cells to the U.S. market in January